18F-氟化钠PET/CT在全心动脉钙化评估中较钙评分和Framingham风险评分提供更清晰的预后信息
该回顾性研究纳入136名参与者(86名健康对照和50名患者),比较18F-NaF PET/CT衍生的SUV值与钙评分及Framingham风险评分在预测患者状态方面的效能。结果显示患者SUVmean和Framingham评分均高于对照,但仅SUVmean能区分患者与对照(AUC=0.63,P=0.049),而Framingham评分不能(AUC=0.44,P=0.38),钙评分和SUVmax无组间差异。
要点
- 患者组SUVmean和Framingham评分高于对照组,但仅SUVmean有判别力。
- SUVmean区分患者与对照的AUC为0.63(P=0.049),Framingham评分无判别力。
- 钙评分和SUVmax在患者与对照间无差异,SUVmean随年龄和BMI增加。
核心结论
- NaF PET/CT衍生的SUVmean在患者与对照间存在差异,而钙评分无差异。
- Framingham风险评分模式与SUVmean相似,但不足以预测患者状态。
- 将NaF PET/CT纳入常规CAD预后评估可能有助于评估冠状动脉早期斑块钙化。
研究设计与样本
- 回顾性研究,纳入136名参与者(86名健康对照和50名患者),年龄21-75岁,BMI 18-43 kg/m2。
- CT心脏分割叠加于PET图像,通过半自动分割法在心脏周围绘制感兴趣体积计算SUV。
- 基于年龄、性别和BMI匹配37对患者/对照进行组间比较,并对全部136名参与者进行回归分析。
主要发现
- 患者平均SUVmean(P=0.006)和Framingham评分(P=0.02)高于对照。
- ROC曲线显示SUVmean可区分患者与对照(AUC=0.63,P=0.049),Framingham评分不能(AUC=0.44,P=0.38)。
- 钙评分和SUVmax在患者与对照间无差异。
- 女性中SUVmean与年龄(partial R2=0.16,P=0.001)和BMI(partial R2=0.12,P=0.004)相关;男性中与年龄(partial R2=0.28,P<0.0001)和BMI(partial R2=0.22,P<0.0001)相关。
关键数值与推荐
- SUVmean区分患者与对照的AUC=0.63,P=0.049。
- Framingham评分区分患者与对照的AUC=0.44,P=0.38。
- 患者与对照SUVmean比较P=0.006,Framingham评分比较P=0.02。
- 女性SUVmean与年龄partial R2=0.16(P=0.001)、与BMI partial R2=0.12(P=0.004);男性与年龄partial R2=0.28(P<0.0001)、与BMI partial R2=0.22(P<0.0001)。
临床怎么用
- NaF PET/CT衍生的SUVmean可能用于辅助识别早期冠状动脉斑块钙化。
- 钙评分和Framingham评分在预测患者状态方面敏感性不足,不宜单独用于早期CAD干预决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To investigate the benefit of utilizing 18F-sodium fluoride (NaF) PET/CT over calcium and Framingham scoring for potential preventative coronary artery disease (CAD) intervention. METHODS AND RESULTS: This retrospective study included 136 participants (ages 21-75, BMI 18-43 kg/m2): 86 healthy controls and 50 patients. CT heart segmentations were superimposed onto PET images and standard uptake values (SUV) were calculated by a semi-auto segmentation method of drawing volumes of interest around the heart. Intergroup comparisons were made matching 37 patient/control pairs based on age, gender, and BMI. ROC curves were generated to determine how well SUV and Framingham methods predicted patient status. Regressions including all 136 participants were performed between SUV, age, and BMI. Patients exhibited higher average SUV (SUVmean; P = 0.006) and Framingham scores (P = 0.02) than controls. However, ROC curves indicated that SUVmean could discriminate patients from controls (AUC = 0.63, P = 0.049), but Framingham scores could not (AUC = 0.44, P = 0.38). Calcium scores and maximum SUV (SUVmax) did not differ between patients and controls. SUVmean correlated with age and BMI among females (age, partial R2 = 0.16, P = 0.001; BMI, partial R2 = 0.12, P = 0.004) and males (age, partial R2 = 0.28, P < 0.0001; BMI, partial R2 = 0.22, P < 0.0001). CONCLUSION: Unlike calcium scores, NaF PET/CT-derived values differed between patients and controls. Framingham risk score patterns echoed those of SUVmean, but were not sensitive enough to predict patient status. SUVmean values increased with age and BMI. Therefore, incorporation of NaF PET/CT into routine prognostic CAD assessment might prove beneficial for assessing early stage plaque calcification in coronary arteries. TRIAL REGISTRATION: ClinicalTrials.gov (NCT01724749).
引用
- Sorci O, Batzdorf AS, Mayer M, et al. 18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification. Eur J Nucl Med Mol Imaging. 2019. PMID: 31734781. doi:10.1007/s00259-019-04590-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。